Quoin Pharmaceuticals, Inc. — Form D
Quoin Pharmaceuticals, Inc. of ASHBURN, VA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-08. The offering totals $22.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-04-08
- Form: D
- Accession: 0001829165-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $22.0M
- Amount sold: $2.0M
- Remaining: $20.0M
- Investors: 1
- Date of first sale: 2021-03-25
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-395159
Issuer
- Name: Quoin Pharmaceuticals, Inc.
- CIK: 0001829165
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 42127 PLEASANT FOREST CT., ASHBURN, VA, 20148
- Phone: 703-980-4182
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Denise Carter | Director | Tel Aviv, L3 |
| Dennis Langer | Director | Naples, FL |
| PETER LANKAU | Director | ASHBURN, VA |
| Natalie Leong | Director | Tel Aviv, L3 |
| Michael Meyers | Director | New York, NY |
| Denise Carter | Executive Officer | Tel Aviv, L3 |
| Michael Meyers | Executive Officer | New York, NY |
| PETER H LANKAU | Director | ASHBURN, VA |
| DENNIS H LANGER | Director | ASHBURN, VA |
Other filings by this issuer (1)
More